Innovation & intellectual property · 17/02/2000Updated: 10/17/2026 · 1 min read
Patent Office Grants Interim Extension for Roboxotine Mesylate Patent
Summary
The U.S. Patent and Trademark Office has issued a certificate for a one-year extension of the term for U.S. Patent No. 4,229,449, which covers roboxotine mesylate.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →